Binge spectrum disorders are prevalent worldwide. Psychiatric and medical comorbidities are common, and societal costs are significant. Evidence-based treatment remains underutilized. Cognitive behavioral therapy is the recommended first-line treatment, but pharmacotherapy may be easier to access.
Interventions:
Meta-analytic evidence directly comparing cognitive behavioral therapy with pharmacotherapy is lacking. We aimed to compare the effects of cognitive behavioral therapy interventions with any pharmacological treatment for binge spectrum disorders. We searched PubMed, Embase, CENTRAL, ClinicalTrials.gov and reference lists for randomized controlled trials comparing cognitive behavioral therapy with any pharmacotherapy for bulimia nervosa/binge eating disorder and performed pairwise meta-analytic evaluations.
Primary Outcomes:
Primary outcomes are remission and frequency of binges. Secondary outcomes are frequency of purges, response, eating disorder psychopathology, weight/body mass index, depression, anxiety, quality of life and dropouts.
Results:
Eleven randomized controlled trials comparing cognitive behavioral therapy with fluoxetine/imipramine/desipramine/methylphenidate/sibutramine were identified (N = 531). Cognitive behavioral therapy was superior to antidepressants in terms of remission, frequency of binges and eating disorder psychopathology. There were no statistically significant differences for any of the individual cognitive behavioral therapy vs drug comparisons in terms of response/depression/anxiety/weight/quality of life/dropouts. Cognitive behavioral therapy was not superior to sibutramine/methylphenidate for the primary outcomes.
Conclusions:
Data are scarce, comparisons underpowered and, considering the inherent methodological limitations of psychotherapy trials, questions arise regarding the presumed superiority of cognitive behavioral therapy. Further research is needed.
AgrasWS (1997) Pharmacotherapy of bulimia nervosa and binge eating disorder: Long-term outcomes. Psychopharmacology Bulletin33: 433–436.
2.
AgrasWS (2019) Cognitive behavior therapy for the eating disorders. Psychiatric Clinics of North America42: 169–179.
3.
AgrasWSBohonC (2021) Cognitive behavioral therapy for the eating disorders. Annual Review of Clinical Psychology17: 417–438.
4.
AgrasWSRossiterEMArnowB, et al. (1992) Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: A controlled comparison. The American Journal of Psychiatry149: 82–87.
5.
AlmohammedOAAlsalemAAAlmangourAA, et al. (2022) Antidepressants and health-related quality of life (HRQoL) for patients with depression: Analysis of the medical expenditure panel survey from the United States. PLoS ONE17: 1–14.
6.
ArgyrouALappasASBakaloudiDR, et al. (2023) Pharmacotherapy compared to placebo for people with bulimia nervosa: A systematic review and meta-analysis. Psychiatry Research327: 115357.
7.
BabbCBredeJJonesCRG, et al. (2022) A comparison of the eating disorder service experiences of autistic and non-autistic women in the UK. European Eating Disorders Review30: 616–627.
8.
BacaltchukJHayPP (2003) Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database of Systematic Reviews4: CD003391.
9.
BacaltchukJHayPTrefiglioR (2001) Antidepressants versus psychological treatments and their combination for bulimia nervosa. The Cochrane Database of Systematic Reviews4: CD003385.
10.
BatterhamRL (2022) Weight stigma in healthcare settings is detrimental to health and must be eradicated. Nature Reviews Endocrinology18: 387–388.
11.
Ben-SheetritJHermonYBirkenfeldS, et al. (2023) Estimating the risk of irreversible post-SSRI sexual dysfunction (PSSD) due to serotonergic antidepressants. Annals of General Psychiatry22: 15.
12.
BrooksSJRask-AndersenMBenedictC, et al. (2012) A debate on current eating disorder diagnoses in light of neurobiological findings: Is it time for a spectrum model?BMC Psychiatry12: 76.
13.
CarterJCFairburnCG (1998) Cognitive-behavioral self-help for binge eating disorder: A controlled effectiveness study. Journal of Consulting and Clinical Psychology66: 616–623.
14.
Castro BaticBHayesD (2020) Exploring harm in psychotherapy: Perspectives of clinicians working with children and young people. Counselling and Psychotherapy Research20: 647–656.
15.
ClaudinoAMPikeKMHayP, et al. (2019) The classification of feeding and eating disorders in the ICD-11: Results of a field study comparing proposed ICD-11 guidelines with existing ICD-10 guidelines. BMC Medicine17: 93.
16.
CroneCFochtmannLJAttiaE, et al. (2023) The American Psychiatric Association practice guideline for the treatment of patients with eating disorders. The American Journal of Psychiatry180: 167–171.
17.
CuijpersPMiguelCHarrerM, et al. (2023) Cognitive behavior therapy vs. control conditions, other psychotherapies, pharmacotherapies and combined treatment for depression: A comprehensive meta-analysis including 409 trials with 52,702 patients. World Psychiatry22: 105–115.
18.
da LuzFQHayPTouyzS, et al. (2018) Obesity with comorbid eating disorders: Associated health risks and treatment approaches. Nutrients10: 829.
19.
DahlgrenCLStedalKRøØ (2017) Eating Disorder Examination Questionnaire (EDE-Q) and Clinical Impairment Assessment (CIA): Clinical norms and functional impairment in male and female adults with eating disorders. Nordic Journal of Psychiatry71: 256–261.
20.
DelinskySSLatnerJDWilsonGT (2006) Binge eating and weight loss in a self-help behavior modification program. Obesity14: 1244–1249.
21.
DerSimonianRLairdN (1986) Meta-analysis in clinical trials. Controlled Clinical Trials7: 177–188.
22.
DevlinMJ (1996) Assessment and treatment of binge-eating disorder. Eating Disorders19: 761–772.
23.
DevlinMJGoldfeinJAPetkovaE, et al. (2005) Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. Obesity Research13: 1077–1088.
24.
EggerMSmithGDSchneiderM, et al. (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ315: 629–634.
25.
EnckPZipfelS (2019) Placebo effects in psychotherapy: A framework. Frontiers in Psychiatry10: 456.
26.
ErskineHEWhitefordHA (2018) Epidemiology of binge eating disorder. Current Opinion in Psychiatry31: 462–470.
27.
FairburnCGHayPJ (1992) The treatment of bulimia nervosa. Annals of Medicine24: 297–302.
28.
FurukawaTAAkechiTWagenpfeilS, et al. (2011) Relative indices of treatment effect may be constant across different definitions of response in schizophrenia trials. Schizophrenia Research126: 212–219.
29.
GhaderiAOdebergJGustafssonS, et al. (2018) Psychological, pharmacological, and combined treatments for binge eating disorder: A systematic review and meta- analysis. Peer Journal6: e5113.
30.
GoldbloomDSOlmstedMDavisR, et al. (1997) A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: Short-term outcome. Behaviour Research and Therapy35: 803–811.
31.
GriloCMMashebRMWilsonGT (2005) Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: A randomized double-blind placebo-controlled comparison. Biological Psychiatry57: 301–309.
32.
GriloCMMashebRMWhiteMA, et al. (2014) Treatment of binge eating disorder in racially and ethnically diverse obese patients in primary care: Randomized placebo-controlled clinical trial of self-help and medication. Behaviour Research and Therapy58: 1–9.
33.
GriloCMIvezajVWhiteMA (2015) Evaluation of the DSM-5 severity indicator for binge eating disorder in a community sample. Behaviour Research and Therapy66: 72–76.
34.
HayPGirosiFMondJ (2015) Prevalence and sociodemographic correlates of DSM-5 eating disorders in the Australian population. Journal of Eating Disorders3: 19.
35.
HayesDZa’baN (2021) What metrics of harm are being captured in clinical trials involving talking treatments for young people? A systematic review of registered studies on the ISRCTN. Counselling and Psychotherapy Research22: 108–129.
36.
HigginsJThomasJChandlerJ, et al. (2019) Cochrane Handbook for Systematic Reviews of Interventions, 2nd Edition.Chichester: John Wiley & Sons.
37.
HigginsJPTAltmanDGGøtzschePC, et al. (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ343: d5928.
38.
HilbertAPetroffDHerpertzS, et al. (2019) Meta-analysis of the efficacy of psychological and medical treatments for binge-eating disorder. Journal of Consulting and Clinical Psychology87: 91–105.
39.
HofmannSGAsnaaniAVonkIJJ, et al. (2012) The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research36: 427–440.
40.
HorowitzMATaylorD (2019) Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry6: 538–546.
41.
HukeVTurkJSaeidiS, et al. (2013) Autism spectrum disorders in eating disorder populations: A systematic review. European Eating Disorders Review21: 345–351.
42.
IqbalARehmanA (2021) Binge Eating Disorder. St. Petersburg, FL: StatPearls Publishing.
43.
JacobiCDahmeBDittmannR (2002) Cognitive-behavioural, fluoxetine and combined treatment for bulimia nervosa: Short- and long-term results. European Eating Disorders Review10: 179–198.
44.
JainAYilanliM (2021) Bulimia Nervosa. St. Petersburg, FL: StatPearls Publishing.
45.
JuulSGluudCSimonsenS, et al. (2020) Blinding in randomised clinical trials of psychological interventions: A retrospective study of published trial reports. BMJ Evidence-Based Medicine26: 109.
46.
KazdinAEFitzsimmons-CraftEEWilfleyDE (2017) Addressing critical gaps in the treatment of eating disorders. International Journal of Eating Disorders50: 170–189.
47.
KesslerRCBerglundPAChiuWT, et al. (2013) The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys. Biological Psychiatry73: 904–914.
48.
LawrenceBJde la Piedad GarciaXKiteJ, et al. (2022) Weight stigma in Australia: A public health call to action. Public Health Research and Practice32: 3–6.
49.
LeitenbergHRosenJCWolfJ, et al. (1994) Comparison of cognitive-behavior therapy and desipramine in the treatment of bulimia nervosa. Behaviour Research and Therapy32: 37–45.
50.
LilienfeldSO (2007) Psychological treatments that cause harm. Perspectives on Psychological Science2: 53–70.
51.
LiuLHayPContiJ (2022) Perspectives on barriers to treatment engagement of people with eating disorder symptoms who have not undergone treatment: A qualitative study. BMC Psychiatry22: 239.
52.
McelroySLGuerdjikovaAIMoriN, et al. (2015) Overview of the treatment of binge eating disorder. CNS Spectrums20: 546–556.
53.
MehlerPSKrantzMJSachsKV (2015) Treatments of medical complications of anorexia nervosa and bulimia nervosa. Journal of Eating Disorders3: 15.
54.
MitchellJEPyleRLEckertED, et al. (1990) A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Archives of General Psychiatry47: 149–157.
55.
MitchellJERaymondNSpeckerS (1993) A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa. International Journal of Eating Disorders14: 229–247.
56.
MoherDLiberatiATetzlaffJ, et al. (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ339: 332–336.
57.
MonteleoneAMPellegrinoFCroattoG, et al. (2022) Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses. Neuroscience & Biobehavioral Reviews142: 104857.
58.
MulkensSWallerG (2021) New developments in cognitive-behavioural therapy for eating disorders (CBT-ED). Current Opinion in Psychiatry34: 576–583.
59.
NICE Guideline (2017) Eating Disorders: Recognition and Treatment. London: NICE.
60.
PalavrasMAHayPFilhoCA, et al. (2017) The efficacy of psychological therapies in reducing weight and binge eating in people with bulimia nervosa and binge eating disorder who are overweight or obese—A critical synthesis and meta-analyses. Nutrients9: 299.
61.
ParryGDCrawfordMJDugganC (2016) Iatrogenic harm from psychological therapies-time to move on. British Journal of Psychiatry208: 210–212.
62.
PeatCMBerkmanNDLohrKN, et al. (2017) Comparative effectiveness of treatments for binge-eating disorder: Systematic review and network meta-analysis. European Eating Disorders Review25: 317–328.
63.
PerkinsNMBrauschAM (2019) Body dissatisfaction and symptoms of bulimia nervosa prospectively predict suicide ideation in adolescents. International Journal of Eating Disorders52: 941–949.
64.
QuiltyLCAllenTADavisC, et al. (2019) A randomized comparison of long acting methylphenidate and cognitive behavioral therapy in the treatment of binge eating disorder. Psychiatry Research273: 467–474.
65.
RamacciottiCEColiEMarazzitiD, et al. (2013) Therapeutic options for binge eating disorder. Eating and Weight Disorders18: 3–9.
66.
RevetARevetARevetA, et al. (2020) Antidepressants and movement disorders: A postmarketing study in the world pharmacovigilance database. BMC Psychiatry20: 308.
67.
RotellaFCastelliniGMontanelliL, et al. (2013) Comparison between normal-weight and overweight bulimic patients. Eating and Weight Disorders18: 389–393.
68.
RufinoKAViswanathHWagnerR, et al. (2018) Body dissatisfaction and suicidal ideation among psychiatric inpatients with eating disorders. Comprehensive Psychiatry84: 22–25.
69.
SharmaSHuckerAMatthewsT, et al. (2021) Cognitive behavioural therapy for anxiety in children and young people on the autism spectrum: A systematic review and meta-analysis. BMC Psychology9: 151.
70.
SladeEKeeneyEMavranezouliI, et al. (2018) Treatments for bulimia nervosa: A network meta-analysis. Psychological Medicine48: 2629–2636.
71.
SminkFRVan HoekenDHoekHW (2013) Epidemiology, course, and outcome of eating disorders. Current Opinion in Psychiatry26: 543–548.
72.
SmithKEEllisonJMCrosbyRD, et al. (2017) The validity of DSM-5 severity specifiers for anorexia nervosa, bulimia nervosa, and binge-eating disorder. International Journal of Eating Disorders50: 1109–1113.
73.
StunkardAJBerkowitzRIWaddenT, et al. (1996) Binge eating disorder and the night-eating syndrome. International Journal of Obesity20: 1–6.
74.
SvaldiJSchmitzFBaurJ, et al. (2019) Efficacy of psychotherapies and pharmacotherapies for bulimia nervosa. Psychological Medicine49: 898–910.
75.
TalumaaBBrownABatterhamRL, et al. (2022) Effective strategies in ending weight stigma in healthcare. Obesity Reviews23: e13494.
76.
TannousWKHayPGirosiF, et al. (2021) The economic cost of bulimia nervosa and binge eating disorder: A population-based study. Psychological Medicine52: 3924–3938.
ThompsonCParkS (2016) Barriers to access and utilization of eating disorder treatment among women. Archives of Women’s Mental Health19: 753–760.
79.
TreasureJDuarteTASchmidtU (2020) Eating disorders. The Lancet395: 899–911.
80.
TrikalinosTAChurchillRFerriM, et al. (2004) Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time. Journal of Clinical Epidemiology57: 1124–1130.
81.
UdoTGriloCM (2019) Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States. International Journal of Eating Disorders52: 42–50.
82.
UdoTBitleySGriloCM (2019) Suicide attempts in US adults with lifetime DSM-5 eating disorders. BMC Medicine17: 120.
83.
Van DisEAMVan VeenSCHagenaarsMA, et al. (2020) Long-term outcomes of cognitive behavioral therapy for anxiety-related disorders: A systematic review and meta-analysis. JAMA Psychiatry77: 265–273.
84.
Van EedenAEVan HoekenDHoekHW (2021) Incidence, prevalence and mortality of anorexia nervosa and bulimia nervosa. Current Opinion in Psychiatry34: 515–524.
85.
VocksSTuschen-CaffierBPietrowskyR, et al. (2010) Meta-analysis of the effectiveness of psychological and pharmacological treatments for binge eating disorder. International Journal of Eating Disorders43: 205–217.
86.
WalshBTWilsonGTLoebKL, et al. (1997) Medication and psychotherapy in the treatment of bulimia nervosa. The American Journal of Psychiatry154: 523–531.
87.
WalshBTFairburnCGMickleyD, et al. (2004) Treatment of bulimia nervosa in a primary care setting. The American Journal of Psychiatry161: 556–561.
88.
WilfleyDEWelchRRSteinRI, et al. (2002) A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. Archives of General Psychiatry59: 713–721.
89.
WilliamsSEWattsTKWadeTD (2012) A review of the definitions of outcome used in the treatment of bulimia nervosa. Clinical Psychology Review32: 292–300.
90.
WilsonGTSyskoR (2009) Frequency of binge eating episodes in bulimia nervosa and binge eating disorder: Diagnostic considerations. International Journal of Eating Disorders42: 603–610.
91.
ZimaBTDevaskarSUShahS, et al. (2022) Imperative to accelerate research aligning real-time clinical demand with mental health supply. Pediatric Research92: 917–920.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
